© 2020

Substance Use Disorders

From Etiology to Treatment

  • Michael A. Nader
  • Yasmin L. Hurd
  • Focuses on each substance used and abused from epidemiology, molecular biology, animal models and human subjects/clinical research reinforcing basic principles of pharmacology throughout

  • Broadens understanding of the commonalities and differences associated with each drug of abuse

  • Provides the reader with state-of-the-art, cutting edge research methods


Part of the Handbook of Experimental Pharmacology book series (HEP, volume 258)

Table of contents

  1. Front Matter
    Pages i-x
  2. Mark Wolfson, Kimberly G. Wagoner, Eunyoung Y. Song, Melinda Pankratz, Sunday Azagba
    Pages 1-29
  3. Gavril W. Pasternak, Steven R. Childers, Ying-Xian Pan
    Pages 89-125
  4. Lisa R. Gerak, David R. Maguire, Charles P. France
    Pages 127-145
  5. Esther Blessing, Sanya Virani, John Rotrosen
    Pages 167-202
  6. Alberto J. López, Cody A. Siciliano, Erin S. Calipari
    Pages 231-263
  7. Maarten E. A. Reith, Margaret E. Gnegy
    Pages 265-297
  8. Lesley D. Schurman, Dai Lu, Debra A. Kendall, Allyn C. Howlett, Aron H. Lichtman
    Pages 323-353
  9. Suzanne Nielsen, Pamela Sabioni, Linda Gowing, Bernard Le Foll
    Pages 355-372
  10. Christie D. Fowler, Jill R. Turner, M. Imad Damaj
    Pages 373-393
  11. Marie N. S. Gendy, Christine Ibrahim, Matthew E. Sloan, Bernard Le Foll
    Pages 395-420
  12. Lorenzo Leggio, Daniel E. Falk, Megan L. Ryan, Joanne Fertig, Raye Z. Litten
    Pages 443-462
  13. Kenichi Tamama, Michael J. Lynch
    Pages 463-502

About this book


The purpose of this book is to provide a broad scope of substance use disorder research and how these findings can impact treatment outcomes. The research and outcomes described in this book represent important principles related to identifying and understanding factors related to substance use disorders. The first section is dedicated to methodology including population-based surveys, basic neuroanatomy, chemistry, molecular biology, behavioral models and brain imaging. The second section utilizes this methodology in research related to opioids, cocaine, marijuana, alcohol and nicotine. The book is aimed at both professionals (academics, clinicians, practitioners) and students or trainees.


Substance Use Disorders Preclinical Research Animal Models Clinical Trials Pharmacology Molecular Biology Chemistry Epidemiology Etiology Treatment

Editors and affiliations

  • Michael A. Nader
    • 1
  • Yasmin L. Hurd
    • 2
  1. 1.Wake Forest School of MedicineWinston-SalemUSA
  2. 2.Addiction Institute of Mount SinaiIcahn School of Medicine at Mount SinaiNew YorkUSA

Bibliographic information

  • Book Title Substance Use Disorders
  • Book Subtitle From Etiology to Treatment
  • Editors Michael A. Nader
    Yasmin L. Hurd
  • Series Title Handbook of Experimental Pharmacology
  • Series Abbreviated Title Hdb Exp.Pharmacology(formerly:Starke,K.:Eds)
  • DOI
  • Copyright Information Springer Nature Switzerland AG 2020
  • Publisher Name Springer, Cham
  • eBook Packages Biomedical and Life Sciences Biomedical and Life Sciences (R0)
  • Hardcover ISBN 978-3-030-33678-3
  • Softcover ISBN 978-3-030-33681-3
  • eBook ISBN 978-3-030-33679-0
  • Series ISSN 0171-2004
  • Series E-ISSN 1865-0325
  • Edition Number 1
  • Number of Pages X, 502
  • Number of Illustrations 1 b/w illustrations, 0 illustrations in colour
  • Topics Pharmacology/Toxicology
  • Buy this book on publisher's site
Industry Sectors
Health & Hospitals
Pharmacology & Toxicology
Consumer Packaged Goods